Viking Therapeutics (NASDAQ:VKTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.

Open	$64.05
Close	$64.63
Volume / Avg.	2.24M / 3.93M
Day Range	$63.02 - $65.32
52 Wk Range	8.28 - 99.41
Market Cap	$7.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	20.48%
Days to Cover	3.17

Recent News

Viking Rises 25% in a Month: Should You Buy or Wait?

Shares of Viking Therapeutics (NASDAQ: VKTX) have soared nearly 25% in the past month, all thanks to progress with its investigational obesity and non-alcoholic steatohepatitis (NASH) candidates, which management plans to advance to late-stage development by early 2025.

Zacks

ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?

Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%

Lekha Gupta

Novo Nordisk Shares Decline Amid Competitive Pressure

Novo Nordisk A/S Common Stock (NYSE: NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).

Vaishali Prayag

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Viking Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of bio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viking Therapeutics (VKTX) stock?

You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.

View our list of the best stock brokerages

Who are Viking Therapeutics (VKTX) competitors?

Other companies in Viking Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Sarepta Therapeutics (NASDAQ:SRPT).

What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?

Viking Therapeutics has a consensus price target of $79.86.

What is the current price for Viking Therapeutics (VKTX)?

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $64.7 last updated August 23, 2024 at 7:52 PM EDT.

Does Viking Therapeutics (VKTX) pay a dividend?

There are no upcoming dividends for Viking Therapeutics.

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics’s Q3 earnings are confirmed for Wednesday, October 23, 2024.

Is Viking Therapeutics (VKTX) going to split?

There is no upcoming split for Viking Therapeutics.

What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'